American Century Companies
TARS icon

American Century Companies’s Tarsus Pharmaceuticals TARS Stock Holding History

American Century Companies’s Portfolio TARS Stock Details TARS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-11,075
Closed -$224K – 2961
2023
Q4 		$224K Buy
11,075
+648
+6% +$10.8K ﹤0.01% 2656
2023
Q3 		$185K Sell
10,427
-793
-7% -$14K ﹤0.01% 2615
2023
Q2 		$203K Buy
+11,220
New +$178K ﹤0.01% 2524

Other funds holding TARS

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

American Century Companies's TARS Position: Q1 2024 in Review

American Century Companies sold out of Tarsus Pharmaceuticals (TARS) in Q1 2024, closing a stake of 11,075 shares — an estimated $224K sold.

American Century Companies first reported a position in TARS in Q2 2023 and held it in 3 quarters. The position peaked at $224K in Q4 2023. 157 funds tracked by Wall St. Rank hold TARS as of Q1 2024.

  • American Century Companies reported no remaining Tarsus Pharmaceuticals position as of Q1 2024 after selling out during the quarter.
  • American Century Companies sold 11,075 Tarsus Pharmaceuticals shares in Q1 2024, an estimated $224K.
  • American Century Companies first reported a position in Tarsus Pharmaceuticals in Q2 2023 and held it in 3 quarters.
  • American Century Companies's Tarsus Pharmaceuticals position peaked at $224K in Q4 2023.
  • 157 funds tracked by Wall St. Rank held Tarsus Pharmaceuticals as of Q1 2024.

Based on American Century Companies's 13F filing for Q1 2024, filed 14 May 2024.